Patterns of predicted T-cell epitopes associated with antigenic drift in influenza H3N2 hemagglutinin

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Homan, E Jane ^a   Bremel, Robert D ^a  

^a IoGenetics LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEMAGGLUTININ 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ; VIRUS PROTEIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIGEN;

ALLELE; AMINO ACID SEQUENCE; ANTIBODY COMBINING SITE; ANTIGEN BINDING; ANTIGEN DETECTION; ANTIGENIC DRIFT; ANTIGENICITY; ARTICLE; BINDING AFFINITY; BIOINFORMATICS; CLUSTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE ASSOCIATION; HELPER CELL; IMMUNOGENETICS; INFLUENZA VIRUS A H3N2; LYMPHOCYTE FUNCTION; MUTATION; NONHUMAN; PREDICTION; PROTEIN INTERACTION; T LYMPHOCYTE; VIRUS ISOLATION; CHEMISTRY; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; PRINCIPAL COMPONENT ANALYSIS; VALIDATION STUDY;

ORTHOMYXOVIRIDAE;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; CLUSTER ANALYSIS; EPITOPES; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; MOLECULAR SEQUENCE DATA; PRINCIPAL COMPONENT ANALYSIS; T-LYMPHOCYTES;

EID: 80055052850     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026711     Document Type: Article

References (72)

1. Suzuki Y, Ito T, Suzuki T, Holland RE Jr, Chambers TM, et al. (2000) Sialic acid species as a determinant of the host range of influenza A viruses. J Virol 74: 11825-11831.
2. Horimoto T, Kawaoka Y, (1994) Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. J Virol 68: 3120-3128.
3. Tewari MK, Sinnathamby G, Rajagopal D, Eisenlohr LC, (2005) A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent. Nat Immunol 6: 287-294 ni1171 [pii];10.1038/ni1171 [doi].
4. Tscherne DM, Garcia-Sastre A, (2011) Virulence determinants of pandemic influenza viruses. J Clin Invest 121: 6-13 44947 [pii];10.1172/JCI44947 [doi].
5. Gerhard W, (2001) The role of the antibody response in influenza virus infection. Curr Top Microbiol Immunol 260: 171-190.
6. Wiley DC, Wilson IA, Skehel JJ, (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289: 373-378.
7. Ferguson NM, Anderson RM, (2002) Predicting evolutionary change in the influenza A virus. Nat Med 8: 562-563 10.1038/nm0602-562 [doi];nm0602-562 [pii].
8. Smith DJ, (2003) Applications of bioinformatics and computational biology to influenza surveillance and vaccine strain selection. Vaccine 21: 1758-1761 S0264410X03000689 [pii].
9. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, et al. (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305: 371-376 10.1126/science.1097211 [doi];1097211 [pii].
10. Plotkin JB, Dushoff J, Levin SA, (2002) Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proc Natl Acad Sci U S A 99: 6263-6268 10.1073/pnas.082110799 [doi];082110799 [pii].
11. Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM, (1999) Predicting the evolution of human influenza A. Science 286: 1921-1925 7945 [pii].
12. Lee MS, Chen JS, (2004) Predicting antigenic variants of influenza A/H3N2 viruses. Emerg Infect Dis 10: 1385-1390.
13. Chi XS, Bolar TV, Zhao P, Tam JS, Rappaport R, et al. (2005) Molecular evolution of human influenza A/H3N2 virus in Asia and Europe from 2001 to 2003. J Clin Microbiol 43: 6130-6132 43/12/6130 [pii];10.1128/JCM.43.12.6130-6132.2005 [doi].
14. Both GW, Sleigh MJ, Cox NJ, Kendal AP, (1983) Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J Virol 48: 52-60.
15. Scherle PA, Palladino G, Gerhard W, (1992) Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J Immunol 148: 212-217.
16. Gerhard W, Mozdzanowska K, Furchner M, Washko G, Maiese K, (1997) Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol Rev 159: 95-103.
17. Thomas PG, Keating R, Hulse-Post DJ, Doherty PC, (2006) Cell-mediated protection in influenza infection. Emerg Infect Dis 12: 48-54.
18. McMichael AJ, Michie CA, Gotch FM, Smith GL, Moss B, (1986) Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J Gen Virol 67 (Pt 4): 719-726.
19. Mozdzanowska K, Furchner M, Maiese K, Gerhard W, (1997) CD4+ T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells. Virology 239: 217-225.
20. Belz GT, Wodarz D, Diaz G, Nowak MA, Doherty PC, (2002) Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J Virol 76: 12388-12393.
21. Babon JA, Cruz J, Orphin L, Pazoles P, Co MD, et al. (2009) Genome-wide screening of human T-cell epitopes in influenza A virus reveals a broad spectrum of CD4(+) T-cell responses to internal proteins, hemagglutinins, and neuraminidases. Hum Immunol 70: 711-721 S0198-8859(09)00144-X [pii];10.1016/j.humimm.2009.06.004 [doi].
22. Richards KA, Chaves FA, Krafcik FR, Topham DJ, Lazarski CA, et al. (2007) Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin. J Virol 81: 7608-7619 JVI.02834-06 [pii];10.1128/JVI.02834-06 [doi].
23. Barnett BC, Graham CM, Burt DS, Skehel JJ, Thomas DB, (1989) The immune response of BALB/c mice to influenza hemagglutinin: commonality of the B cell and T cell repertoires and their relevance to antigenic drift. Eur J Immunol 19: 515-521 10.1002/eji.1830190316 [doi].
24. Gianfrani C, Oseroff C, Sidney J, Chesnut RW, Sette A, (2000) Human memory CTL response specific for influenza A virus is broad and multispecific. Hum Immunol 61: 438-452 S0198-8859(00)00105-1 [pii].
25. Voeten JT, Bestebroer TM, Nieuwkoop NJ, Fouchier RA, Osterhaus AD, et al. (2000) Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes. J Virol 74: 6800-6807.
26. Boon AC, de MG, Graus YM, Fouchier RA, Sintnicolaas K, et al. (2002) Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. J Virol 76: 2567-2572.
27. Berkhoff EG, Geelhoed-Mieras MM, Jonges M, Smith DJ, Fouchier RA, et al. (2007) An amino acid substitution in the influenza A virus hemagglutinin associated with escape from recognition by human virus-specific CD4+ T-cells. Virus Res 126: 282-287 S0168-1702(07)00058-5 [pii];10.1016/j.virusres.2007.02.018 [doi].
28. Berkhoff EG, Boon AC, Nieuwkoop NJ, Fouchier RA, Sintnicolaas K, et al. (2004) A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro. J Virol 78: 5216-5222.
29. VanoOsten AR, McGill J, Legge KL, (2010) Quantification of the frequency and multiplicity of infection of respiratory- and lymph node-resident dendritic cells during influenza virus infection. PLoS One 5: e12902 10.1371/journal.pone.0012902 [doi].
30. Hamilton-Easton A, Eichelberger M, (1995) Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice. J Virol 69: 6359-6366.
31. Crowe SR, Turner SJ, Miller SC, Roberts AD, Rappolo RA, et al. (2003) Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections. J Exp Med 198: 399-410 10.1084/jem.20022151 [doi];jem.20022151 [pii].
32. Nimmerjahn F, Dudziak D, Dirmeier U, Hobom G, Riedel A, et al. (2004) Active NF-kappaB signalling is a prerequisite for influenza virus infection. J Gen Virol 85: 2347-2356 10.1099/vir.0.79958-0 [doi];85/8/2347 [pii].
33. Bremel RD, Homan EJ, (2010) An integrated approach to epitope analysis I: Dimensional reduction, visualization and prediction of MHC binding using amino acid principal components and regression approaches. Immunome Res 6: 7 1745-7580-6-7 [pii];10.1186/1745-7580-6-7 [doi].
34. Bremel RD, Homan EJ, (2010) An integrated approach to epitope analysis II: A system for proteomic-scale prediction of immunological characteristics. Immunome Res 6: 8 1745-7580-6-8 [pii];10.1186/1745-7580-6-8 [doi].
35. Lund O, Nielsen M, Lundegaard C, Kesmir C, Brunak S, (2005) Immunological Bioinformatics Cambridge, MA MIT Press.
36. SAS Institute Inc (2010) JMP® 9 Modelling and Multivariate Methods Cary, NC SAS Institute Inc.
37. Wold S, Sjorstrom M, Eriksson L, (2001) PLS-regression: a basic tool of chemometrics. Chemometrics and Intelligent Laboratory Systems 58: 109-130.
38. Greenbaum J, Sidney J, Chung J, Brander C, Peters B, et al. (2011) Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics 10.1007/s00251-011-0513-0 [doi].
39. Pham DT, Dimov S, Nguyen CD, (2005) Selection of K in K-means clustering. J Mech Eng Sci 219: 103-119.
40. Savitzky A, Golay MJE, (1964) Smoothing and differentiation of data by simplified least squares procedures. Anal Chem 36: 1627-1639.
41. Desmet J, Meersseman G, Boutonnet N, Pletinckx J, De CK, et al. (2005) Anchor profiles of HLA-specific peptides: analysis by a novel affinity scoring method and experimental validation. Proteins 58: 53-69 10.1002/prot.20302 [doi].
42. Johnson NL, (1949) Systems of frequency curves generated by methods of translation. Biometrika 36: 149-176.
43. Baumgartner CK, Ferrante A, Nagaoka M, Gorski J, Malherbe LP, (2010) Peptide-MHC class II complex stability governs CD4 T cell clonal selection. J Immunol 184: 573-581 jimmunol.0902107 [pii];10.4049/jimmunol.0902107 [doi].
44. Lazarski CA, Chaves FA, Jenks SA, Wu S, Richards KA, et al. (2005) The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance. Immunity 23: 29-40 S1074-7613(05)00202-5 [pii];10.1016/j.immuni.2005.05.009 [doi].
45. Constant SL, Bottomly K, (1997) Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 15: 297-322 10.1146/annurev.immunol.15.1.297 [doi].
46. Roti M, Yang J, Berger D, Huston L, James EA, et al. (2008) Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus. J Immunol 180: 1758-1768 180/3/1758 [pii].
47. Crowe SR, Miller SC, Brown DM, Adams PS, Dutton RW, et al. (2006) Uneven distribution of MHC class II epitopes within the influenza virus. Vaccine 24: 457-467 S0264-410X(05)00779-6 [pii];10.1016/j.vaccine.2005.07.096 [doi].
48. Barnett BC, Hartlmayr I, Graham CM, Thomas DB, (1990) Single amino acid residues in a synthetic peptide of influenza haemagglutinin, HA 1 177-199, distinguish I-Ad- and I-Ed-restricted T-cell epitopes. Immunology 70: 48-54.
49. Hioe CE, Dybdahl-Sissoko N, Philpott M, Hinshaw VS, (1990) Overlapping cytotoxic T-lymphocyte and B-cell antigenic sites on the influenza virus H5 hemagglutinin. J Virol 64: 6246-6251.
50. Sette A, Moutaftsi M, Moyron-Quiroz J, McCausland MM, Davies DH, et al. (2008) Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities. Immunity 28: 847-858 S1074-7613(08)00235-5 [pii];10.1016/j.immuni.2008.04.018 [doi].
51. Topham DJ, Doherty PC, (1998) Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells. J Virol 72: 882-885.
52. Mozdzanowska K, Furchner M, Zharikova D, Feng J, Gerhard W, (2005) Roles of CD4+ T-cell-independent and-dependent antibody responses in the control of influenza virus infection: evidence for noncognate CD4+ T-cell activities that enhance the therapeutic activity of antiviral antibodies. J Virol 79: 5943-5951.
53. Mozdzanowska K, Furchner M, Maiese K, Gerhard W, (1997) CD4+ T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells. Virology 239: 217-225 S0042-6822(97)98882-6 [pii];10.1006/viro.1997.8882 [doi].
54. Batista FD, Iber D, Neuberger MS, (2001) B cells acquire antigen from target cells after synapse formation. Nature 411: 489-494 10.1038/35078099 [doi];35078099 [pii].
55. Tong JC, Simarmata D, Lin RT, Renia L, Ng LF, (2010) HLA class I restriction as a possible driving force for Chikungunya evolution. PLoS One 5: e9291 10.1371/journal.pone.0009291 [doi].
56. de Campos-Lima PO, Gavioli R, Zhang QJ, Wallace LE, Dolcetti R, et al. (1993) HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science 260: 98-100.
57. Bedford T, Cobey S, Beerli P, Pascual M, (2010) Global migration dynamics underlie evolution and persistence of human influenza A (H3N2). PLoS Pathog 6: e1000918 10.1371/journal.ppat.1000918 [doi].
58. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, et al. (2008) The global circulation of seasonal influenza A (H3N2) viruses. Science 320: 340-346 320/5874/340 [pii];10.1126/science.1154137 [doi].
59. Koelle K, Cobey S, Grenfell B, Pascual M, (2006) Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314: 1898-1903 314/5807/1898 [pii];10.1126/science.1132745 [doi].
60. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, et al. (2008) The genomic and epidemiological dynamics of human influenza A virus. Nature 453: 615-619 nature06945 [pii];10.1038/nature06945 [doi].
61. Lebiush M, Rannon L, Kark JD, (1981) The relationship between epidemic influenza (A(H1N1) and ABO blood group. J Hyg (Lond) 87: 139-146.
62. Maruyama N, Yoshida Y, Inamatsu T, Fujita K, Handa S, et al. (2004) HLA-DR allotype is associated with responsiveness to influenza vaccine in elderly Japanese. Geriat Gerentol Int 4: 234-237.
63. Gelder CM, Lambkin R, Hart KW, Fleming D, Williams OM, et al. (2002) Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine. J Infect Dis 185: 114-117 JID010636 [pii];10.1086/338014 [doi].
64. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA, (2008) Evidence for a heritable predisposition to death due to influenza. J Infect Dis 197: 18-24 10.1086/524064 [doi].
65. Poland GA, Ovsyannikova IG, Jacobson RM, (2008) Immunogenetics of seasonal influenza vaccine response. Vaccine 26 (Suppl 4): D35-D40.
66. Ruben FL, Fireman P, LaPorte RE, Drash AL, Uhrin M, et al. (1988) Immune responses to killed influenza vaccine in patients with type 1 diabetes: altered responses associated with HLA-DR 3 and DR 4. J Lab Clin Med 112: 595-602.
67. Giannella M, Alonso M, Garcia dV, Roa PL, Catalan P, et al. (2010) Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients. Clin Microbiol Infect 10.1111/j.1469-0691.2010.03399.x [doi].
68. Pinsky BA, Mix S, Rowe J, Ikemoto S, Baron EJ, (2010) Long-term shedding of influenza A virus in stool of immunocompromised child. Emerg Infect Dis 16: 1165-1167.
69. Li CC, Wang L, Eng HL, You HL, Chang LS, et al. (2010) Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children. Emerg Infect Dis 16: 1265-1272.
70. Murcia PR, Baillie GJ, Daly J, Elton D, Jervis C, et al. (2010) Intra- and interhost evolutionary dynamics of equine influenza virus. J Virol 84: 6943-6954 JVI.00112-10 [pii];10.1128/JVI.00112-10 [doi].
71. Iqbal M, Xiao H, Baillie G, Warry A, Essen SC, et al. (2009) Within-host variation of avian influenza viruses. Philos Trans R Soc Lond B Biol Sci 364: 2739-2747 364/1530/2739 [pii];10.1098/rstb.2009.0088 [doi].
72. Cagigi A, Nilsson A, Pensieroso S, Chiodi F, (2010) Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy. Lancet Infect Dis 10: 499-503 S1473-3099(10)70117-1 [pii];10.1016/S1473-3099(10)70117-1 [doi].